Table 1.
Cohort Characteristics
| Patient characteristics | Total (N = 26,006) | Continuity of care | Usual provider of care |
|---|---|---|---|
| — | 0.40 (0.26–0.60)a | 0.60 (0.50–0.80)a | |
| Age | |||
| <65 y | 9049 (34.8) | 0.43 (0.26–0.62) | 0.63 (0.50–0.80) |
| 65–74 y | 9655 (37.1) | 0.40 (0.25–0.60) | 0.60 (0.50–0.80) |
| >75 y | 7302 (28.1) | 0.40 (0.27–0.60) | 0.63 (0.50–0.80) |
| Sex | |||
| Male | 12,702 (48.8) | 0.40 (0.27–0.60) | 0.6 (0.50–0.80) |
| Female | 13,304 (51.2) | 0.40 (0.26–0.60) | 0.6 (0.50–0.80) |
| Race | |||
| White | 19,985 (76.9) | 0.40 (0.27–0.60) | 0.60 (0.50–0.80) |
| Black | 3028 (11.6) | 0.40 (0.20–0.60) | 0.60 (0.50–0.80) |
| Hispanic | 1386 (5.3) | 0.43 (0.27–0.62) | 0.63 (0.50–0.80) |
| Other | 1607 (6.2) | 0.43 (0.27–0.67) | 0.63 (0.50–0.82) |
| Medicaid status | |||
| Full | 9390 (36.1) | 0.44 (0.27–0.67) | 0.67 (0.50–0.83) |
| Partial | 3260 (12.5) | 0.40 (0.27–0.60) | 0.63 (0.50–0.80) |
| None | 13,356 (51.4) | 0.40 (0.25–0.59) | 0.60 (0.50–0.78) |
| Disabled | 11,730 (45.1) | 0.42 (0.26–0.61) | 0.63 (0.50–0.80) |
| Location of residence | |||
| Urban | 21,036 (80.9) | 0.40 (0.25–0.60) | 0.60 (0.50–0.80) |
| Region | |||
| Midwest | 5248 (20.2) | 0.40 (0.24–0.60) | 0.60 (0.50–0.80) |
| Northeast | 4821 (18.6) | 0.40 (0.24–0.60) | 0.60 (0.50–0.80) |
| South | 10,670 (41.1) | 0.40 (0.27–0.60) | 0.60 (0.50–0.80) |
| West | 5201 (20.1) | 0.46 (0.29–0.67) | 0.67 (0.50–0.83) |
| Unknown | 66 (0.2) | 0.40 (0.29–0.52) | 0.60 (0.50–0.75) |
| Characteristics of cirrhosis | |||
| Alcoholic cirrhosis | 2612 (10.0) | 0.47 (0.28–0.67) | 0.67 (0.50–0.83) |
| Hepatitis C virus-related cirrhosis | 5134 (19.7) | 0.40 (0.22–0.60) | 0.60 (0.50–0.78) |
| Nonviral nonalcohol-related cirrhosis | 18,345 (70.5) | 0.42 (0.26–0.64) | 0.60 (0.50–0.80) |
| Ascites | 183 (0.7) | 0.40 (0.27–0.61) | 0.60 (0.45–0.80) |
| Varices | 1082 (4.2) | 0.37 (0.24–0.50) | 0.57 (0.50–0.75) |
| Hepatic encephalopathy | 2037 (7.8) | 0.40 (0.27–0.60) | 0.63 (0.50–0.80) |
| Hepatocellular carcinoma | 650 (2.5) | 0.36 (0.20–0.51) | 0.57 (0.44–0.75) |
| Transjugular intrahepatic portosystemic shunt | 185 (0.7) | 0.33 (0.24–0.50) | 0.57 (0.43–0.75) |
| Paracentesis | 951 (3.7) | 0.38 (0.25–0.54) | 0.60 (0.45–0.75) |
| Spontaneous bacterial peritonitis | 40 (0.2) | 0.37 (0.30–0.58) | 0.63 (0.55–0.77) |
| Charlson comorbidity index | |||
| 0 | 1507 (5.8) | 0.47 (0.30–0.67) | 0.67 (0.50–0.83) |
| 1 | 3182 (12.2) | 0.44 (0.29–0.67) | 0.67 (0.50–0.82) |
| 2 | 3642 (14) | 0.42 (0.27–0.60) | 0.63 (0.50–0.80) |
| 3+ | 17,675 (68) | 0.40 (0.25–0.60) | 0.60 (0.50–0.80) |
| End-stage renal disease | 1413 (5.4) | 0.40 (0.22–0.60) | 0.60 (0.50–0.80) |
NOTE. Values are median (interquartile range).
a
n (%).